Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study

J Strosberg, N Mizuno, T Doi, E Grande, JP Delord, R Shapira-Frommer, E Bergsland, M Shah, M Fakih, S Takahashi, SA Piha-Paul, B O'Neil, Sajeve Thomas, Martijn Lolkema, MH Chen, N Ibrahim, K Norwood, J Hadoux

Research output: Contribution to journalArticleAcademicpeer-review

162 Citations (Scopus)
Original languageEnglish
Pages (from-to)2124-2130
Number of pages7
JournalClinical Cancer Research
Volume26
Issue number9
DOIs
Publication statusPublished - 2020

Research programs

  • EMC NIHES-02-67-01

Cite this